VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DLB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DLBDolby Laboratories, Inc.
$52.12$5.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDLBFinancials

Dolby Laboratories, Inc. (DLB) Financials

23Y historyFree accessUpdated daily

Operating margins exhibit significant volatility, swinging from 9.7% in 2025Q4 to 29.1% in 2026Q2, reflecting the high operating leverage inherent in the company's R&D-heavy cost structure.

DLB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03
Sales/Revenue1.36B1.35B1.27B1.3B1.25B1.28B1.16B1.24B1.05B1.08B1.03B970.64M960.18M909.67M926.26M955.5M922.71M719.5M640.23M482.03M391.54M327.97M289.04M217.47M
Revenue Growth %3.39%5.92%-2%3.67%-2.14%10.28%-6.43%17.73%-2.48%5.43%5.68%1.09%5.55%-1.79%-3.06%3.55%28.24%12.38%32.82%23.11%19.38%13.47%32.91%-
Cost of Goods Sold171.46M160.13M140.5M152.57M141.36M130.03M146.5M160.85M127.56M118.31M108.98M94.82M70.18M96.72M92.03M111.17M122.22M84.81M67.78M74.27M76.04M80.22M91.5M73.64M
COGS % of Revenue-11.87%11.03%11.74%11.27%10.15%12.61%12.96%12.1%10.94%10.62%9.77%7.31%10.63%9.94%11.63%13.25%11.79%10.59%15.41%19.42%24.46%31.66%33.86%
Gross Profit1.19B1.19B1.13B1.15B1.11B1.15B1.02B1.08B927.04M963.15M916.76M875.82M890M812.96M834.24M844.33M800.49M634.69M572.45M407.76M315.5M247.75M197.54M143.83M
Gross Margin %87.44%88.13%88.97%88.26%88.73%89.85%87.39%87.04%87.9%89.06%89.38%90.23%92.69%89.37%90.06%88.37%86.75%88.21%89.41%84.59%80.58%75.54%68.34%66.14%
Gross Profit Growth %-4.92%-1.22%3.12%-3.37%13.39%-6.06%16.58%-3.75%5.06%4.67%-1.59%9.48%-2.55%-1.2%5.48%26.12%10.87%40.39%29.24%27.35%25.42%37.34%-
Operating Expenses938.84M924.04M868.51M884.36M895.21M810.47M794.73M787.13M743.98M701.66M683.73M662.27M613.88M561.82M471.05M411.19M354.49M292.2M286.17M222.91M189.54M165.69M129.94M94.85M
OpEx % of Revenue-68.49%68.19%68.04%71.4%63.26%68.41%63.4%70.55%64.88%66.66%68.23%63.93%61.76%50.86%43.03%38.42%40.61%44.7%46.24%48.41%50.52%44.95%43.62%
Selling, General & Admin656.62M647.24M604.85M612.84M634.03M556.83M555.69M549.26M507.19M468.35M464.12M460.95M430.75M393.07M330.91M287.27M249.51M225.49M224.09M178.8M154.16M135.16M106.46M76.59M
SG&A % of Revenue-47.97%47.49%47.15%50.57%43.46%47.83%44.24%48.09%43.31%45.25%47.49%44.86%43.21%35.73%30.07%27.04%31.34%35%37.09%39.37%41.21%36.83%35.22%
Research & Development266.18M261.79M263.66M271.52M261.17M253.64M239.04M237.87M236.79M233.31M219.61M201.32M183.13M168.75M140.14M123.92M104.98M66.71M62.08M44.11M35.38M30.53M23.48M18.26M
R&D % of Revenue-19.4%20.7%20.89%20.83%19.8%20.58%19.16%22.45%21.57%21.41%20.74%19.07%18.55%15.13%12.97%11.38%9.27%9.7%9.15%9.04%9.31%8.12%8.4%
Other Operating Expenses1.45M15.01M0000000000000000000000
Operating Income254.61M264.96M264.71M262.81M217.23M340.76M220.56M293.63M183.06M261.49M233.03M213.55M276.12M251.14M363.18M433.14M446M342.5M286.28M184.85M125.96M82.06M67.6M47.67M
Operating Margin %18.65%19.64%20.78%20.22%17.33%26.6%18.98%23.65%17.36%24.18%22.72%22%28.76%27.61%39.21%45.33%48.34%47.6%44.72%38.35%32.17%25.02%23.39%21.92%
Operating Income Growth %-0.09%0.72%20.99%-36.25%54.5%-24.89%60.4%-29.99%12.21%9.12%-22.66%9.95%-30.85%-16.15%-2.88%30.22%19.63%54.87%46.76%53.49%21.39%41.82%-
EBITDA357.24M363.56M352.04M358.33M320.84M436.62M311.44M378.76M264.34M345.8M318.18M282.68M329.4M304.38M407.06M477.13M480.94M371.23M311.1M199.66M138.84M93.41M76.12M55.16M
EBITDA Margin %26.17%26.95%27.64%27.57%25.59%34.08%26.81%30.51%25.07%31.98%31.02%29.12%34.31%33.46%43.95%49.94%52.12%51.59%48.59%41.42%35.46%28.48%26.33%25.37%
EBITDA Growth %-5.54%3.27%-1.76%11.69%-26.52%40.19%-17.77%43.28%-23.56%8.68%12.56%-14.18%8.22%-25.22%-14.69%-0.79%29.55%19.33%55.82%43.81%48.63%22.72%37.98%-
D&A (Non-Cash Add-back)102.63M98.6M87.33M95.51M103.61M95.86M90.88M85.12M81.28M84.31M85.15M69.13M53.28M53.24M43.88M43.99M34.94M28.73M24.81M14.8M12.88M11.35M8.52M7.5M
EBIT278.32M279.97M312.48M250.05M215.28M354.51M239.72M282.31M196.37M256.64M235.9M245.78M276.1M250.65M369.19M440.64M437.71M372.35M303.93M212.53M148.41M93.07M70.44M0
Net Interest Income10.08M15.38M34.08M28.09M6.57M3.49M12.72M24.92M18.97M9.58M5.68M4.54M3.34M3.85M6.21M10M6.59M10.33M15.76M23.05M16.96M5.11M-912K-2.15M
Interest Income14.19M15.38M34.08M28.09M6.57M3.49M12.72M24.92M18.97M9.58M5.68M4.54M3.34M3.85M6.41M10M7.3M11.27M17.89M26.16M18.73M6.96M1.44M0
Interest Expense4.12M0000000000000196K0703K935K2.13M3.11M1.77M1.85M2.35M2.15M
Other Income/Expense33.88M38.53M47.77M-12.76M-1.95M13.75M19.15M-11.33M13.31M-4.84M2.88M32.23M-22K-490K5.81M7.5M-8.99M28.92M15.52M24.56M20.68M9.16M491K-219K
Pretax Income288.49M303.49M312.48M250.05M215.28M354.51M239.72M282.31M196.37M256.64M235.9M245.78M276.1M250.65M368.99M440.64M437.01M371.42M301.8M209.42M146.64M91.22M68.09M47.61M
Pretax Margin %21.14%22.49%24.53%19.24%17.17%27.67%20.63%22.74%18.62%23.73%23%25.32%28.75%27.55%39.84%46.12%47.36%51.62%47.14%43.44%37.45%27.81%23.56%21.89%
Income Tax43.15M46.99M48.16M48.41M31.38M36.69M8.1M26.8M154.07M54.22M49.5M62.54M67.38M60.34M103.86M130.06M154.19M127.07M100.77M65.13M55.83M37.33M27.32M16.08M
Effective Tax Rate %14.96%15.48%15.41%19.36%14.58%10.35%3.38%9.49%78.46%21.13%20.98%25.45%24.4%24.08%28.15%29.52%35.28%34.21%33.39%31.1%38.08%40.92%40.12%33.77%
Net Income243.65M255.02M261.82M200.66M184.09M310.23M231.36M255.15M41.75M201.8M185.86M181.39M206.1M189.27M264.3M309.27M283.45M242.99M199.46M142.83M89.55M52.29M39.84M30.97M
Net Margin %17.85%18.9%20.56%15.44%14.68%24.21%19.91%20.55%3.96%18.66%18.12%18.69%21.47%20.81%28.53%32.37%30.72%33.77%31.15%29.63%22.87%15.94%13.78%14.24%
Net Income Growth %-5.06%-2.6%30.48%9%-40.66%34.09%-9.32%511.2%-79.31%8.58%2.46%-11.99%8.89%-28.39%-14.54%9.11%16.65%21.83%39.65%59.5%71.24%31.25%28.65%-
Net Income (Continuing)245.33M256.49M264.32M201.64M183.9M317.82M231.62M255.5M42.3M202.43M186.4M183.24M208.72M190.3M265.13M310.58M282.83M244.35M201.03M144.28M90.8M53.89M40.77M-
Discontinued Operations000000000000000000000000
Minority Interest9.14M9.39M9.73M17.08M4.84M6.25M5.76M5.68M6.57M7.1M8.48M8.94M21.63M18.92M22.96M21.84M20.94M22M22.1M22.28M19.91M18.26M17.2M16.13M
EPS (Diluted)2.552.622.691.961.812.972.252.441.141.951.811.731.991.842.462.752.462.111.741.260.800.500.430.36
EPS Growth %-4.53%-2.6%37.24%8.29%-39.06%32%-7.79%114.04%-41.54%7.73%4.62%-13.07%8.15%-25.2%-10.55%11.79%16.59%21.26%38.1%57.5%60%16.28%19.44%-
EPS (Basic)-2.662.742.001.843.072.302.511.181.981.851.752.021.862.472.782.502.151.791.310.850.540.470.36
Diluted Shares Outstanding95.52M97.48M97.33M97.59M101.98M104.62M102.94M104.57M106.98M103.29M102.42M103.86M103.63M102.79M107.54M112.55M115.39M115.37M114.78M113.57M111.66M104.22M92.78M86.08M
Basic Shares Outstanding95.22M95.87M95.54M95.79M99.99M101.19M100.56M101.63M103.38M101.78M100.72M102.35M102.15M101.88M106.93M111.44M113.45M113.1M111.49M109.2M105.69M96.97M85.56M85.01M
Dividend Payout Ratio-49.64%43.76%51.53%54.36%28.74%38.29%30.37%158.47%28.27%26.04%22.61%-215.67%----------

Key Metrics

Growth RegimeMixed
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Royalty-free codec adoption

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Cyclical Revenue Patterns Persist

As reported in recent financial statements, DLB's revenue growth remains inconsistent, fluctuating between a 2.9% contraction in 2026Q1 and a 7.1% expansion in 2026Q2, reflecting the inherent volatility of the company's reliance on consumer electronics shipment cycles and the timing of licensing royalty recognitions.

The revenue trajectory suggests a mature business model that is highly sensitive to the cadence of global OEM product launches. Investors should monitor whether the recent uptick in 2026Q2 represents a sustainable recovery or merely a seasonal anomaly driven by the timing of royalty reporting.

Structural Gross Margin Resilience

Based on the company's reported figures, gross margins have consistently hovered near 88%, underscoring the high-margin nature of its intellectual property licensing model despite the occasional drag introduced by the lower-margin hardware and services segment during periods of increased operational investment.

This exceptional margin profile indicates significant pricing power and a low marginal cost of delivery for its core codec technologies. However, the slight compression observed in certain quarters warrants further investigation into whether this reflects a shift in product mix or increased competitive pressure on royalty rates.

Operating Leverage Remains Highly Variable

According to the income statement data, operating margins have swung significantly from 9.7% in 2025Q4 to 29.1% in 2026Q2, suggesting that the company's fixed cost base, particularly in R&D, creates substantial operating leverage that amplifies bottom-line results during periods of revenue growth.

The lack of consistent operating margin expansion implies that management continues to prioritize heavy investment in R&D to maintain its technological moat. This strategy appears to protect the company's long-term competitive position but results in significant earnings volatility when top-line growth stalls.

Stock-Based Compensation Impacts Earnings

As indicated by the quarterly filings, the company's net income is periodically impacted by significant stock-based compensation expenses, which reached $37.2 million in 2026Q1, thereby creating a notable divergence between GAAP earnings and the underlying cash-generative capacity of the core licensing business.

The presence of these non-cash charges suggests that investors should focus on cash flow metrics to gauge the true economic performance of the firm. The variability in these expenses may indicate a management strategy that uses equity-based incentives to align employee interests with long-term R&D objectives.

Royalty-Free Codec Adoption Risks

While the company maintains a dominant market position, the rise of royalty-free alternatives like AV1, as noted in industry context, poses a long-term threat to the sustainability of the current licensing revenue model, potentially forcing a structural reduction in royalty rates to maintain market share.

The market may be underestimating the risk that 'good enough' audio and video standards could eventually erode the company's pricing power in the mobile and streaming segments. Investors should monitor the adoption rates of these open-source alternatives as a leading indicator of potential future margin compression.

DLB — Frequently Asked Questions

Quick answers to the most common questions about buying DLB stock.

What was Dolby Laboratories, Inc.'s (DLB) revenue in 2025?

For fiscal year 2025, Dolby Laboratories, Inc. (DLB) reported total revenue of $1.35B. This represents a 520.4% increase compared to $217.5M in 2003.

Is Dolby Laboratories, Inc. (DLB) profitable?

Dolby Laboratories, Inc. (DLB) is profitable, generating $255.0M in net income for the fiscal year ending 2025 with a net profit margin of 18.9%.

What is Dolby Laboratories, Inc.'s operating profit margin?

Dolby Laboratories, Inc. (DLB) reported an operating income of $265.0M, resulting in an operating profit margin of 19.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Dolby Laboratories, Inc.'s gross profit and gross margin?

Dolby Laboratories, Inc. (DLB) generated $1.19B in gross profit for the year, representing a gross profit margin of 88.1%. This demonstrates the company's core pricing power and production efficiency.